The Southwest Hospital of Amu — Chongqing, Chongqing Municipality

Public research footprint of The Southwest Hospital of Amu, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Hepatitis B, Chronic · HR-positive, HER2-negative Breast Neoplasms · Non-Small Cell Lung Cancer · Gastric Cancer, Gastroesophageal Junction Cancer

Recently updated registry entries

NCT04723004 — Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus… (Completed)
NCT07407803 — Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1… (Recruiting)
NCT07569757 — Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Southwest Hospital of Amu?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.